Why Scottish Patients Choose Between These Two Options
Wegovy vs Mounjaro Scotland: Understanding the Key Differences
When researching Wegovy Scotland options, many patients discover that Mounjaro represents a compelling alternative worth considering. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormones, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors for dual-action appetite control. Both prescription-only medicines require clinical assessment and ongoing medical supervision, but their mechanisms differ significantly in how they support weight management alongside a reduced-calorie diet and increased physical activity. Scottish patients often appreciate having both options available through one trusted pharmacy rather than switching providers mid-treatment.
The dosing schedules also vary considerably between these treatments. Wegovy follows a structured 5-dose escalation from 0.25mg to 2.4mg maintenance over 16 weeks, whilst Mounjaro offers 6 dose levels from 2.5mg up to 15mg, allowing for more granular titration based on individual response and tolerability. EverydayMeds stocks the complete range of both treatments, ensuring continuity of supply whether you're prescribed the Wegovy step-up protocol or Mounjaro's flexible dosing approach.
Wegovy Scotland Pricing Compared to Mounjaro Costs
Wegovy Scotland pricing through EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenience for the escalation phase, with the Intro Duo (0.25mg & 0.5mg) available for £169.99 and the complete Intro Trio spanning three months for £299.99. New customers apply discount code FIRST40 at checkout to reach these final prices, whilst returning patients use DOSE25 for continued savings.
Mounjaro pricing follows a different structure due to its distinct dosing schedule, with costs varying based on the prescribed strength and titration requirements. Both treatments represent significant investments in medically-supervised weight management, but EverydayMeds' bundle options help Scottish patients plan their treatment costs effectively. The Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance supply for £649.99, offering supply security for established patients who've reached their optimal dose through our GPhC-registered pharmacy (#9012878).
Clinical Evidence: STEP Trials vs SURMOUNT Studies
Wegovy's clinical foundation rests on the landmark STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo when combined with lifestyle interventions. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, expanding Wegovy's clinical profile beyond weight management alone. These results reflect treatment alongside a reduced-calorie diet and increased physical activity, as required by the MHRA licensing conditions.
Mounjaro's evidence base derives from the SURMOUNT clinical programme, though direct comparison of trial weight loss percentages isn't appropriate due to different study designs and patient populations. Both treatments underwent rigorous evaluation before MHRA approval, and both require specialist prescriber oversight to ensure appropriate patient selection and monitoring. Scottish patients benefit from accessing either option through EverydayMeds' clinical assessment process, allowing prescribers to recommend the most suitable treatment based on individual medical history and treatment goals.
How Wegovy Works: GLP-1 Mechanism in Detail
Wegovy's semaglutide targets GLP-1 receptors in your brain's appetite centres, mimicking the natural incretin hormones that signal fullness after meals. This mechanism may help reduce food cravings and promote earlier satiety, supporting portion control efforts when combined with nutritional guidance and physical activity. The once-weekly injection maintains steady hormone levels, avoiding the peaks and troughs associated with daily medications. Patients often report reduced appetite within the first few weeks, though individual responses vary considerably. The dose escalation protocol allows your body to adjust gradually, minimising gastrointestinal side effects whilst building therapeutic effectiveness over the 16-week titration period.
Ordering Process: From Assessment to Delivery Across Scotland
EverydayMeds streamlines access to both Wegovy and Mounjaro through our 3-minute online clinical assessment, designed to gather the medical information our prescribers need for safe treatment decisions. Standard prescriber review takes 3 working days, with 24-hour express review available for urgent cases across Scotland. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit to Glasgow, Edinburgh, Aberdeen, and all Scottish locations. Our GPhC-registered pharmacy ensures every shipment meets pharmaceutical standards for temperature-controlled medicines. Payment processing includes automatic application of discount codes FIRST40 or DOSE25, giving you immediate access to our lowest prices without waiting for promotional periods.
Storage and Practical Considerations for Scottish Patients
Wegovy offers a significant practical advantage over Mounjaro regarding storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This extended stability suits Scottish lifestyles, whether you're travelling to the Highlands, working offshore, or simply prefer not to worry about immediate refrigeration after delivery. Both treatments use pre-filled injection pens, but Wegovy's FlexTouch delivery system offers dose confirmation and proven reliability across millions of injections worldwide. The once-weekly dosing schedule fits naturally into most routines, with many patients choosing the same day each week for consistency. Proper disposal through local pharmacy needle exchange programmes ensures environmental responsibility and community safety.
Why Scottish Patients Research Wegovy vs Mounjaro Comparisons
The growing interest in Wegovy Scotland versus Mounjaro reflects patients' desire to make informed treatment decisions rather than accepting the first option presented. Scottish healthcare consumers increasingly research prescription-only medicines before consultations, seeking to understand mechanisms, costs, and practical implications of long-term treatment. EverydayMeds supports this approach by providing both options through one trusted pharmacy relationship, eliminating the need to establish new clinical relationships if treatment switching becomes necessary.
Many patients appreciate that neither treatment requires permanent commitment – both can be discontinued under medical supervision if circumstances change or alternative approaches become preferable. This flexibility, combined with EverydayMeds' comprehensive support for both options, allows Scottish patients to focus on treatment success rather than pharmacy logistics throughout their weight management journey.
Making Your Choice: Clinical Guidance and Next Steps
While both Wegovy and Mounjaro have demonstrated clinical effectiveness in their respective trial programmes, the choice between them depends on individual medical history, lifestyle factors, and treatment preferences that only a qualified prescriber can properly evaluate. EverydayMeds' clinical assessment process considers these factors alongside your BMI, comorbidities, and previous treatment experiences to recommend the most appropriate option. Our prescribers regularly review emerging evidence for both treatments, ensuring recommendations reflect current best practice guidelines from NICE and professional medical bodies. Whether you proceed with Wegovy's established GLP-1 approach or Mounjaro's dual-receptor mechanism, ongoing medical supervision ensures safe, effective treatment tailored to your specific needs. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment, with both treatments available for next-day delivery across Scotland once your prescription is approved.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
